AzTrials
AzTrials

PeriodontitisNCT06091228

The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy

A study testing tongue scraper in people with Periodontitis and Halitosis, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Periodontitis can lead to tooth loss which may impair chewing ability and aesthetics. In addition, periodontitis can give rise to halitosis. Standard initial periodontal treatment consists of supra and subgingival biofilm reduction and removal of calculus. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Periodontitis, Halitosis, Tongue Condition
What is being tested?
tongue scraper
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
1 siteBelgium
Study dates
1 Sep 2024to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Males or females American Society of Anesthesiologist classification I of II,
  • 18 years of age or older,
  • In good general health as documented by self-assessment
  • Suffer from generalised periodontitis (according to 2018 classification)
  • Suffer from halitosis with suspected intra-oral cause: organoleptic score (OLS) of 2 or higher by an experienced oral malodour judge
Show all 10Show fewer
  • At least one volatile sulphur compounds(VSCs) measurement above the following thresholds:
  • Portable sulphur detector (Halimeter) > 107 ppb
  • Oral Chroma™: hydrogen sulfide (H₂S) > 112ppb
  • Oral Chroma™: methyl mercaptan (CH3SH) >28ppb

Who cannot join

  • Participant has a history of chemotherapy or radiotherapy in head and neck area
  • Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
  • Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial
  • Female who is pregnant, breast-feeding or has the intention of becoming pregnant in the following 6 months
  • Participation in another interventional Trial with an investigational medicinal product (IMP) or device
  • Recent intake of antibiotics (3 months prior to the first consultation)
Show all 15Show fewer
  • Antibiotics indicated as part of the periodontal treatment
  • Use of antibiotics during the course of the study
  • Suffer from halitosis with suspected extra-oral cause
  • Suffer from a systemic disease that could cause extra-oral halitosis (e.g. diabetes mellitus, liver or kidney failure, trimethylaminuria)
  • Participant has a history of rheumatic fever, neurological deficiencies, or use of medication which may affect periodontal tissue, (phenytoin, cyclosporin, nifedipine, chronic use of non-steroidal anti-inflammatory drugs)
  • Presence of active caries lesions
  • Unwillingness to return for the follow-up examination
  • Wear partial prosthetic dentures removables
  • Participant has less than 20 teeth

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium1 site, 1 recruiting
  • UZLeuven, Campus SintRafael

    Leuven

    Jesica Dadamio, 0032 473128176, jesica.dadamio@kuleuven.be

    Ana B Castro Sarda, DDS, PhD, Prof

    Recruiting

Other trials in Belgium

About this study

Official title: The Additional Effect of Including Tongue Scraping to the Oral Hygiene Instructions on Halitosis Parameters in Periodontitis Patients Undergoing Standard Initial Periodontal Therapy

Periodontitis can lead to tooth loss which may impair chewing ability and aesthetics. In addition, periodontitis can give rise to halitosis.

Standard initial periodontal treatment consists of supra and subgingival biofilm reduction and removal of calculus. Recently, the European Federation of Periodontology introduced clinical practice guidelines for the treatment of periodontitis. The use of a tongue scraper is not mentioned as element in the standard initial treatment of periodontitis.

The investigators have planned a clinical study in order to provide information about the effect of standard initial periodontal therapy and the additional effect of the use of a tongue scraper as part of the oral hygiene instructions on halitosis parameters in periodontitis patients.

Being tested
tongue scraper
Keywords
periodontitis, halitosis, oral malodor, tongue coating, tongue cleaning, non-surgical treatment
Medical subject headings
Periodontitis, Halitosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tongue scraperOther

    tongue cleaning with gentle strokes twice a day covering the whole surface of the tongue

Study groups in NCT06091228
Study groupRoleWhat they receive
Control- No tongue scraping full length of studyNo interventionOral hygiene instructions before and after non-surgical treatment without inclusion of tongue scraper
Test 1 - tongue scraping full length of studyExperimentalOral hygiene instructions before and after non-surgical treatment with inclusion of tongue scraper
Receives: Other: tongue scraper
Test 2 - tongue scraping only after non-surgical therapyExperimentalOral hygiene instructions before and after non-surgical treatment with inclusion of tongue scraper only after treatment
Receives: Other: tongue scraper

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improving of halitosis parameters (organoleptic scores)

    Reduction in organoleptic scores measured in a six point intensity scale proposed by Rosenberg and colleagues. The different scores of this scale are defined as :

    • 0: no odour (below the smell threshold)
    • 1: barely noticeable odour
    • 2: slight odour
    • 3: moderate odour
    • 4: strong odour
    • 5: extremely strong odour, close to saturation

    Measured: 18 weeks

Secondary outcomes (3)
  1. Improving of volatile sulphur compounds (VSCs)

    Reduction in concentration of VSCs in breath samples measured in ppb by 2 devices (Halimeter, OralChroma CHM-2)

    Measured: 18 weeks

  2. improving of periodontal parameters

    Reduction in pocket depth (PD) measured by a proving tool in mm (0 to 10)

    Measured: 18 weeks

  3. improving of oral hygiene parameters.

    reduction in full mouth bleeding score (FMBS) and full mouth plaque score (FMPS) Scores are given as % of measured sites (0 to 100). The higher the number, the worse the oral hygiene.

    Measured: 18 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2023
  2. Study start1 Sep 2024
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
39 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06091228
Sponsor's protocol ID
S67590
Status last verified
Feb 2026
First submitted
13 Oct 2023
Last updated
13 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing tongue scraper in people with Periodontitis and Halitosis, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ana Castro (+3216332407, ana.castro@uzleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improving of halitosis parameters (organoleptic scores) (time frame: 18 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in